Search
News
Earnings
LP Building Solutions Q3 2026 Earnings: Record Siding Sales Leave Adjusted EBITDA Flat
LP Building Solutions (NYSE: LPX) reported Q3 2026 net sales of $691 million, up about 4% year over year, and diluted EPS of $0.32 versus $0.13. Siding sales reached a record $473 million, rising 7%, while consolidated adjusted EBITDA remained flat at $82 million as higher raw-material, freight, labor, maintenance, and inventory-related costs absorbed pricing and volume gains. Operating cash flow was $112 million. For Q4, LP guided to consolidated adjusted EBITDA of $30 million to $40 million, including an expected $35 million OSB adjusted EBITDA loss.
TradingKey
Tue, Nov 3
Earnings
Gartner Q3 2026 Earnings: Adjusted Revenue Grew Despite a GAAP Decline
Gartner’s Q3 2026 revenue was $1.505 billion, down 1.3% year over year, while adjusted revenue rose 2.4% after excluding the divested Digital Markets operation. Diluted EPS increased to $3.35 from $0.47, though the comparison benefited from a $154 million prior-year impairment and a lower share count. Adjusted EPS rose 30.1% to $3.59, adjusted EBITDA grew 7.5% to $364 million, and free cash flow increased 2.2% to $275 million. FX-neutral contract value reached $5.3 billion, up 2.5%.
TradingKey
Tue, Nov 3
Earnings
Revvity Q3 2026 Earnings: Margins Expand as Guidance Rises
Revvity (RVTY) reported Q3 2026 revenue of $728.9 million, up 4.3% year over year, while GAAP EPS from continuing operations increased to $0.56 from $0.41. Adjusted operating margin expanded to 28.7% from 26.1%, and operating cash flow from continuing operations rose to $166.7 million. Life Sciences led reported growth, while Diagnostics declined on a reported basis but grew pro forma. Revvity raised its pro forma 2026 outlook, excluding China IDX, to approximately $2.86 billion of revenue and $5.40-$5.45 of adjusted EPS.
TradingKey
Tue, Nov 3
Earnings
ADM Q3 2026 Earnings: Biofuels Lift Segment Profit and Full-Year Guidance
ADM reported Q3 2026 adjusted diluted EPS of $1.77, up from $0.92, while total segment operating profit rose 64% to $1.382 billion. North American biofuels margins drove gains in Crushing, Refined Products and Vantage Corn Processors, offsetting weaker Ag Services and Human Nutrition. ADM raised full-year adjusted EPS guidance to approximately $5.50-$5.80, reflecting expected fourth-quarter operating profit improvement across all segments. Investors should monitor biofuels policy, energy prices, mark-to-market effects, Nutrition execution and international trade conditions. Capital spending plans were also reduced to prioritize high-return investments.
TradingKey
Tue, Nov 3
Earnings
Henry Schein Q3 2026 Earnings: Dental Growth Supports Higher Guidance
Henry Schein’s Q3 2026 revenue rose 4.0% to $3.47 billion, while GAAP diluted EPS increased 26.2% to $1.06 and adjusted EBITDA margin expanded 40 basis points to 9.24%. U.S. dental merchandise sales climbed 8.6%, primarily on volume and market-share gains, while value-added services fell 4.8%. The company raised full-year non-GAAP EPS guidance to $5.50–$5.56 and upgraded adjusted EBITDA growth to high single digits, while maintaining total sales growth guidance of 4.5%–5.5%. Operating cash flow declined to $161 million from $174 million despite higher quarterly earnings.
TradingKey
Tue, Nov 3
Earnings
Leidos Q3 FY2026 Earnings: EPS Rises 16% on 4% Revenue Growth
Leidos (NYSE: LDOS) reported fiscal Q3 2026 revenue of $4.63 billion, up 4% year over year, while GAAP diluted EPS increased 16% to $3.28 and non-GAAP EPS rose 19% to $3.62. Homeland revenue climbed 32%, helped by the ENTRUST acquisition, but Health revenue declined 12% and companywide organic growth was 0.6%. Quarterly free cash flow fell to $476 million from $680 million. Leidos lowered its full-year revenue range while raising non-GAAP EPS and operating cash flow guidance.
TradingKey
Tue, Nov 3
Indices
US Dollar: Midterms pose limited downside – ING
ING strategists argue that the US Dollar’s reaction to the midterm elections should be short-lived. They see some short-term downside risk if Democrats win both chambers, mainly via regulation concerns and gridlock fears, but stress that the Federal Reserve narrative remains dominant.
Fxstreet
Tue, Nov 3
Commodities
Gold struggles near $3,900 as traders assess Middle East developments,US election risks
Gold (XAU/USD) loses momentum on Tuesday as Oil prices rebound after the Wall Street Journal (WSJ) reported a US strike on Iran’s Qeshm Island, dampening optimism over diplomatic efforts that had sent energy prices sharply lower the previous day.
Earnings
DuPont Q3 2026 Earnings: Organic Growth and Margin Expansion Lift Results
DuPont’s Q3 2026 net sales rose 4% to $1.868 billion, with organic sales up 5%, while adjusted EPS increased 62% to $2.09. Operating EBITDA grew 8% to $469 million and margin expanded 80 basis points to 25.1%, supported by organic growth and productivity across Healthcare & Water Technologies and Diversified Industrials. Operating cash flow from continuing operations reached $410 million, and DuPont raised its full-year 2026 outlook to about $1.785 billion of operating EBITDA and adjusted EPS of $7.47 to $7.52.
TradingKey
Tue, Nov 3
Earnings
IDEAYA Q3 2026 Earnings: Darovasertib NDA Submitted as Net Loss Widens
IDEAYA Biosciences’ Q3 2026 earnings showed collaboration revenue of $10.2 million, up from $8.9 million in Q2, while net loss widened to $125.7 million and diluted loss per share remained $1.22. Cash, cash equivalents, and marketable securities ended the quarter at $1.15 billion, supporting an unchanged runway into 2030 under the current plan. The quarter’s central development was completion of the darovasertib-plus-crizotinib NDA submission, alongside the decision to close OptimUM-010 and redirect an estimated $100 million to $125 million of savings.
TradingKey
Tue, Nov 3
Forex
British Pound trades flat while US Midterm Elections take centre stage
The British Pound (GBP) trades almost flat at around 1.3410 against the US Dollar (USD) during the European trading session on Tuesday. The GBP/USD pair consolidates as investors shift their focus to United States (US) Midterm Elections, which will begin later in the North American session.
Fxstreet
Tue, Nov 3
Stocks
LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization
LIPSIA-STRATEGY evaluated whether revascularization guided by angiography-based FFR using CAAS vFFR (vessel Fractional Flow Reserve), delivers clinical outcomes comparable to guidance by pressure wire-based FFR. Conclusive trial results provide further randomized clinical evidence validating CAAS ...PR Newswire
Tue, Nov 3
Stocks
Convera accelerates global growth strategy with appointment of payments veteran Craig McDonald
Tasked with scaling strategic partnerships and channels to accelerate customer acquisition and revenue growth worldwide SEATTLE and LONDON, Nov. 3, 2026 /PRNewswire/ -- Convera, a global leader in commercial payments, today announced the appointment of Craig McDonald as Senior Vice President, Globa...PR Newswire
Tue, Nov 3
Stocks
Differentia Bio Advances Human Digital Twins with AI-Driven Disease Modeling and Clinical Validation
From millions of molecular measurements to clinically supported therapeutic predictions, Differentia is building AI-powered disease environments for pharmaceutical R&D. SAN FRANCISCO, Nov. 3, 2026 /PRNewswire/ -- Differentia Bio, a developer of AI-powered human disease digital twins, today anno...PR Newswire
Tue, Nov 3
Stocks
SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopliteal Disease
Late-breaking data presented at TCT 2026and published simultaneously in JACC: Cardiovascular Interventionsshow durable benefit with MagicTouch PTA, with similar walking capacity, quality of life and safety in both groups TAMPA, Fla., Nov. 3, 2026 /PRNewswire/ --Three-year results from the ra...PR Newswire
Tue, Nov 3
Cryptocurrencies
Crypto Today: Bitcoin, Ethereum, XRP under pressure as investors pull capital
Bitcoin (BTC) trades downward at $76,566 on Tuesday, testing six-week lows. The Crypto King's path of least resistance has remained largely sideways after the historic $6.3 billion Binance hack last week, with prevailing doldrums linked to reduced risk appetite and capital outflows.
Featured Tools
Top News
DomoAI Launches InkoAI Agent - One Sentence to Ready-to-Post Video
Gold Price Forecast: Gold Tumbles Below $3,900 as Trump Says No Need for Iran Deal; Can October PPI Spur a Rebound?
US October PPI Preview: Fed Rate Hike Expectations Rise, PPI May Be Key Variable; How Will US Stocks, Dollar, and Gold Move?
【US Pre-Market】Nvidia Rebounds Over 2%; Microsoft Falls Over 2% Amid Massive Global Outage; October PPI Due
Nasdaq Extends Drop by 0.91% as Tech Stocks Lead Declines, AMD Falls Nearly 9%, Nvidia Drops 2%
